| 2025-12-02 |
复牌提示：
2025-12-01 19:50:00 停牌，复牌日期 2025-12-02 09:00:00
|
| 2025-11-26 |
详情>>
股本变动：
变动后总股本11600.00万股
变动原因 ▼▲
- 原因：
- a one-for-ten reverse stock split of the Company's common stock
|
| 2025-11-26 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2025-10-09 |
详情>>
业绩披露：
2026年一季报每股收益0.00美元,归母净利润-32.2万美元,同比去年增长99.18%
|
| 2025-10-09 |
财报披露：
美东时间 2025-10-09 盘前发布财报
|
| 2025-09-26 |
股东大会：
将于2025-11-18召开股东大会
会议内容 ▼▲
- 1.To elect John Herhalt as Class I director nominee, to serve until his term expires or until his successor is duly elected and qualified, as described herein;
2.To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending May 31, 2026;
3.Approval of the non-binding advisory resolution on the named executive officer compensation;
4.To approve the governance changes to the Company’s Fifth Amended and Restated Certificate of Incorporation (the “Charter”) to (i) declassify the Board and provide that all directors will be elected at each annual meeting of stockholders and (ii) eliminate the provision of the Charter that allows stockholders to remove directors only for cause (collectively, the “Governance Proposal”);
5.To consider and act upon any other business that may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2025-09-26 |
股东大会：
将于2025-11-18召开股东大会
会议内容 ▼▲
- 1.To elect John Herhalt as Class I director nominee, to serve until his term expires or until his successor is duly elected and qualified, as described herein;
2.To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending May 31, 2026;
3.Approval of the non-binding advisory resolution on the named executive officer compensation;
4.To approve the governance changes to the Company’s Fifth Amended and Restated Certificate of Incorporation (the “Charter”) to (i) declassify the Board and provide that all directors will be elected at each annual meeting of stockholders and (ii) eliminate the provision of the Charter that allows stockholders to remove directors only for cause (collectively, the “Governance Proposal”);
5.To consider and act upon any other business that may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2025-07-31 |
详情>>
内部人交易：
FALTISCHEK DENISE M等共交易9笔
|
| 2025-07-29 |
详情>>
业绩披露：
2023年年报每股收益-2.35美元,归母净利润-14.53亿美元,同比去年增长-204.67%
|
| 2025-07-29 |
详情>>
业绩披露：
2025年年报每股收益-2.46美元,归母净利润-21.87亿美元,同比去年增长-792.62%
|
| 2025-04-28 |
股东大会：
将于2025-06-10召开股东大会
会议内容 ▼▲
- 1.The approval of an amendment to our Fifth Amended and Restated Certificate of Incorporation to effect a reverse stock split of our common stock by a ratio of not less than one-for-ten and not more than one-for-twenty (the “Reverse Stock Split”), with the exact ratio to be set within this range by our board of directors (the “Board of Directors”) in its sole discretion (without reducing the authorized number of shares of our common stock) and with our Board of Directors able to elect to abandon such proposed amendment and not effect the Reverse Stock Split authorized by our stockholders in its sole discretion (the “Amendment Proposal”);
2.The approval of the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Amendment Proposal.
|
| 2025-04-28 |
股东大会：
将于2025-06-10召开股东大会
会议内容 ▼▲
- 1.The approval of an amendment to our Fifth Amended and Restated Certificate of Incorporation to effect a reverse stock split of our common stock by a ratio of not less than one-for-ten and not more than one-for-twenty (the “Reverse Stock Split”), with the exact ratio to be set within this range by our board of directors (the “Board of Directors”) in its sole discretion (without reducing the authorized number of shares of our common stock) and with our Board of Directors able to elect to abandon such proposed amendment and not effect the Reverse Stock Split authorized by our stockholders in its sole discretion (the “Amendment Proposal”);
2.The approval of the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Amendment Proposal.
|
| 2025-04-08 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-1.06美元,归母净利润-9.14亿美元,同比去年增长-328.61%
|
| 2025-01-10 |
详情>>
业绩披露：
2025年中报每股收益-0.14美元,归母净利润-1.25亿美元,同比去年增长-3.3%
|
| 2024-10-10 |
详情>>
业绩披露：
2025年一季报每股收益-0.04美元,归母净利润-3916.5万美元,同比去年增长45.24%
|
| 2024-09-27 |
股东大会：
将于2024-11-21召开股东大会
会议内容 ▼▲
- 1.To elect David Hopkinson and Thomas Looney as Class III director nominees, each to serve until his term expires or until his successor is duly elected and qualified, as described herein;
2.To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending May 31, 2025;
3.To approve an increase in the number of shares of common stock the Company is authorized to issue from 1,208,000,000 shares of capital stock to 1,426,000,000 shares of capital stock (the “Authorized Shares Proposal”);
4.To approve the governance changes to the Company’s Fourth Amended and Restated Certificate of Incorporation (the “Charter”) to (i) declassify the Board and provide that all directors will be elected at each annual meeting of stockholders and (ii) eliminate the provision of the Charter that allows stockholders to remove directors only for cause (collectively, the “Governance Proposal”);
5.To consider and act upon any other business that may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2024-09-27 |
股东大会：
将于2024-11-21召开股东大会
会议内容 ▼▲
- 1.To elect David Hopkinson and Thomas Looney as Class III director nominees, each to serve until his term expires or until his successor is duly elected and qualified, as described herein;
2.To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending May 31, 2025;
3.To approve an increase in the number of shares of common stock the Company is authorized to issue from 1,208,000,000 shares of capital stock to 1,426,000,000 shares of capital stock (the “Authorized Shares Proposal”);
4.To approve the governance changes to the Company’s Fourth Amended and Restated Certificate of Incorporation (the “Charter”) to (i) declassify the Board and provide that all directors will be elected at each annual meeting of stockholders and (ii) eliminate the provision of the Charter that allows stockholders to remove directors only for cause (collectively, the “Governance Proposal”);
5.To consider and act upon any other business that may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2024-07-30 |
详情>>
业绩披露：
2024年年报每股收益-0.33美元,归母净利润-2.45亿美元,同比去年增长83.14%
|
| 2024-07-30 |
详情>>
业绩披露：
2022年年报每股收益-0.99美元,归母净利润-4.77亿美元,同比去年增长-29.77%
|
| 2024-04-09 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.29美元,归母净利润-2.13亿美元,同比去年增长83.77%
|
| 2024-01-09 |
详情>>
业绩披露：
2024年中报每股收益-0.17美元,归母净利润-1.21亿美元,同比去年增长15.68%
|
| 2023-10-04 |
详情>>
业绩披露：
2024年一季报每股收益-0.1美元,归母净利润-7152.5万美元,同比去年增长2.66%
|
| 2023-09-27 |
股东大会：
将于2023-11-21召开股东大会
会议内容 ▼▲
- 1.To elect the Class II director nominees, each to serve until his or her term expires or until his or her successor is duly elected and qualified, as described herein;
2.To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending May 31, 2024;
3.Approval of the non-binding advisory resolution on the named executive officer compensation;
4.Approval to increase the number of shares of common stock the Company is authorized to issue from 990,000,000 shares of capital stock to 1,208,000,000 shares of capital stock (the “Authorized Shares Proposal”);
5.Approval of the governance changes to the Company’s Third Amended and Restated Certificate of Incorporation (the “Charter”) to (i) declassify the Board and provide that all directors will be elected at each annual meeting of stockholders and (ii) eliminate the provision of the Charter that allows stockholders to remove directors only for cause (collectively, the “Governance Proposal”);
6.To consider and act upon any other business that may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2023-09-27 |
股东大会：
将于2023-11-21召开股东大会
会议内容 ▼▲
- 1.To elect the Class II director nominees, each to serve until his or her term expires or until his or her successor is duly elected and qualified, as described herein;
2.To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending May 31, 2024;
3.Approval of the non-binding advisory resolution on the named executive officer compensation;
4.Approval to increase the number of shares of common stock the Company is authorized to issue from 990,000,000 shares of capital stock to 1,208,000,000 shares of capital stock (the “Authorized Shares Proposal”);
5.Approval of the governance changes to the Company’s Third Amended and Restated Certificate of Incorporation (the “Charter”) to (i) declassify the Board and provide that all directors will be elected at each annual meeting of stockholders and (ii) eliminate the provision of the Charter that allows stockholders to remove directors only for cause (collectively, the “Governance Proposal”);
6.To consider and act upon any other business that may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2022-10-03 |
股东大会：
将于2022-11-22召开股东大会
会议内容 ▼▲
- 1.To elect the Class I director nominee, to serve until his term expires or until his successor is duly elected and qualified, as described herein;
2.To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending May 31, 2023;
3.To approve the amendments to the Company’s Certificate of Incorporation, as amended (the “Charter”) to cancel the Class 1 common stock and re-allocate such authorized shares to Class 2 common stock (the amendments, the “Charter Amendments” and the proposal, the “Charter Amendment Proposal”);
4.To consider and act upon any other business that may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2021-09-24 |
股东大会：
将于2021-11-22召开股东大会
会议内容 ▼▲
- 1.All of the Class I, Class II and Class III director nominees, to serve until their respective terms expire or until their successors are duly elected and qualified, as described herein;
2.The non-binding advisory resolution on the named executive officer compensation;
3.The ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the current fiscal year;
4.Any other business properly brought before the Annual Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-06-25 |
股东大会：
将于2021-07-29召开股东大会
会议内容 ▼▲
- 1.Increase the number of shares of common stock we are authorized to issue from 743,333,333 shares of capital stock to 990,000,000 shares of capital stock;
2.Elect not to be governed by Section 203 of Delaware General Corporation Law;
3.Permit stockholders of the Company to take action by written consent;
4.Approve four sub-proposals related to other governance changes to the Certificate of Incorporation:
a)Eliminate the dual structure of Class 1 Common Stock and Class 2 Common Stock, and instead authorize the issuance of two classes of stock of the Company: (i) Common Stock and (ii) Preferred Stock,
b)Declassify the board of directors of the Company and provide that all such directors will be elected at each annual meeting of stockholder,
c)Remove limitations on the corporate opportunity doctrine, which generally provides that officers and directors may not divert to themselves or their affiliates any business opportunity presented to, or otherwise rightfully belonging to, the Company,
d)Provide that the directors of the Company may be removed with or without cause at any time by the holders of a majority of the voting power of the Company’s then-outstanding shares of capital stock, subject to the rights of holders of Preferred Stock;
5.Effect other changes to the Certificate of Incorporation to eliminate certain provisions related to the Company’s prior status as a “controlled company,” which are no longer applicable and to make other administrative and conforming amendments and changes as necessary in light of the foregoing proposals.
6.Approve the adjournment of the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt any of the above proposals;
7.Transact other business that may properly come before the Special Meeting.
|
| 2021-03-12 |
股东大会：
将于2021-04-16召开股东大会
会议内容 ▼▲
- 1.To consider and vote on a proposal to increase the authorized capital stock of Tilray from 743,333,333 shares to 900,000,000 shares of capital stock, consisting of 890,000,000 shares of Class 2 common stock and 10,000,000 shares of preferred stock, as reflected in the amendment to the second amended and restated certificate of incorporation of Tilray attached as Appendix “F” to the Circular (the “Tilray Charter Amendment”), which is further described in the accompanying joint circular and proxy statement (the “Circular”) and a copy of the Tilray Charter Amendment is attached as Appendix “F” (the “Tilray Charter Amendment Proposal”).
2.To consider and vote on a proposal to issue Tilray Class 2 common stock (the “ Tilray Shares ”) to Aphria Shareholders pursuant to the arrangement agreement dated December 15, 2020, as amended on February 19, 2021 between Aphria Inc. and Tilray (the “ Arrangement Agreement ”), which is further described in the Circular, including in the section entitled “The Arrangement Agreement and Related Agreements” beginning on page 115 of the Circular, and a copy of the Arrangement Agreement is attached as Appendix “A” (the “ Tilray Share Issuance Proposal ”);
3.To consider and approve, on an advisory (non-binding) basis, the compensation that may be paid to Tilray’s named executive officers that is based on or otherwise relates to the transactions contemplated by the Arrangement Agreement, which is further described in the Circular, including in the section entitled “Interests of Tilray’s Directors and Management in the Arrangement” beginning on page 96 of the Circular (the “ Tilray Advisory Compensation Proposal ”);
4.To approve the adjournment of the Tilray Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies in the event there are not sufficient votes at the time of the Tilray Meeting to approve the Tilray Charter Amendment Proposal or the Tilray Share Issuance Proposal (the “Tilray Adjournment Proposal”).
|
| 2020-04-30 |
股东大会：
将于2020-05-28召开股东大会
会议内容 ▼▲
- 1.To elect the two nominees for director named herein to the Board of Directors to hold office until the 2023 Annual Meeting of Stockholders.
2.To approve the issuance of securities for purposes of Nasdaq Listing Rule 5635(d).
3.To ratify the selection by the Audit Committee of the Board of Directors of Deloitte LLP as our independent registered public accounting firm of the Company for its fiscal year ending December 31, 2020.
4.To approve a non-binding advisory resolution on the frequency of future advisory votes on the compensation of named executive officers.
5.To conduct any other business properly brought before the meeting.
|
| 2019-04-15 |
股东大会：
将于2019-05-30召开股东大会
会议内容 ▼▲
- 1.To elect the two nominees for director named herein to the Board of Directors to hold office until the 2022 Annual Meeting of Stockholders.
2.To ratify the selection by the Audit Committee of the Board of Directors of Deloitte LLP as our independent registered public accounting firm of the Company for its fiscal year ending December 31, 2019.
3.To conduct any other business properly brought before the meeting.
|